Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: With investigation of the potential role of community-associated MRSA strains

Journal of Infection

Volumn 61, Issue 6, 2010, Pages 449-457

  Wang, Jann Tay ^a   Wang, Jiun Ling ^b   Fang, Chi Tai ^a,c   Chie, Wei Chu ^c   Lai, Mei Shu ^c   Lauderdale, Tsai Ling ^d   Weng, Chia Min ^a   Chang, Shan Chwen ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b E DA HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Multilocus sequence typing; Staphylococcal cassette chromosome mec; Vancomycin

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; MINOCYCLINE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANEMIA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; COMORBIDITY; DRUG BLOOD LEVEL; FEMALE; GENE CASSETTE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTILOCUS SEQUENCE TYPING; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPTIC SHOCK; TAIWAN; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TAIWAN;

EID: 78649634980     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.09.029     Document Type: Article

References (39)

1. Centers for Diseases Control and Prevention Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999, 48:707-710.
2. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infections. J Am Med Assoc 2003, 290:2976-2984.
3. Weber J.T. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2005, 41:S269-S272.
4. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
5. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002, 359:1819-1827.
6. Ito T., Katayama Y., Asada K., Mori N., Tsutsumimoto K., Tiensasitorn C., et al. Structural comparison of the three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001, 45:1323-1336.
7. Ma X.X., Ito T., Tiensasitorn C., Jamklang M., Chongtrakool P., Boyle-Vavra S., et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002, 46:1147-1152.
8. King M.D., Humphrey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006, 144:309-317.
9. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., et al. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
10. Seybold U., Kourbatova E.V., Johnson J.G., Halvosa S.J., Wang Y.F., King M.D., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42:647-656.
11. Maree C.L., Daum R.S., Boyle-Vavra S., Matayoshi K., Miller L.G. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007, 13:236-242.
12. Ito T., Ma X.X., Takeuchi F., Yuzawa H., Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassett chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004, 48:2637-2651.
13. Wang C.C., Lo W.T., Chu M.L., Siu L.K. Epidemiology typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 2004, 39:481-487.
14. T or SCC mec type IV. J Clin Microbiol 2005, 43:4719-4730.
15. Lo W.T., Lin W.J., Tseng M.H., Wang S.R., Chu M.L., Wang C.C. Community-acquired methicillin-resistant Staphylococcus aureus in Children, Taiwan. Emerg Infect Dis 2006, 12:1267-1270.
16. Wang J.T., Liao C.H., Fang C.T., Chie W.C., Lai M.S., Lauderdale T.L., et al. Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol 2009, 47:2957-2963.
17. Chen C.J., Su L.H., Chiu C.H., Chie W.C., Lai M.S., Lauderdale T.L., et al. Clinical features and molecular characteristics of invasive community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Diagn Microbiol Infect Dis 2007, 59:287-293.
18. Wang J.L., Chen S.Y., Wang J.T., Wu G.H., Chiang W.C., Hsueh P.R., et al. Comparison of both clinical features and mortality risk associated with bloodstream infection due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008, 46:799-806.
19. Wang J.T., Sheng W.H., Wang J.L., Chen D., Chen M.L., Chen Y.C., et al. Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Antimicrob Chemother 2008, 62:514-517.
20. Huang Y.C., Su L.H., Wu T.L., Lin T.Y. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates from a teaching hospital in northern Taiwan. J Clin Microbiol 2006, 44:2268-2270.
21. Moise P.A., Sakoulas G., Forrest A., Schentag J.J. Vancomycin in vitro bacterial activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bloodstream infection. Antimicrob Agents Chemother 2007, 51:2582-2586.
22. Soriano A., Marco F., Martinez J.A., Pisos E., Almela M., Dimova V.P., et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008, 46:193-200.
23. Fang C.T., Shau W.Y., Hsueh P.R., Chen Y.C., Wang J.T., Hung C.C., et al. Early empirical glycopeptides therapy for patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on the outcome. J Antimicrob Chemother 2006, 57:511-519.
24. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bloodstream infection: a meta-analysis. Clin Infect Dis 2003, 36:53-59.
25. Wang J.T., Sheng W.H., Chen M.Y., Fang C.T., Hsieh S.M., Hsueh P.R., et al. Nosocomial bloodstream infection in human immunodeficiency virus-infected patients in Taiwan: descriptive epidemiology and risk factors for mortality. J Formos Med Assoc 2004, 103:743-748.
26. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
27. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
28. Tseng Y.C., Wang J.T., Wu F.L., Chen Y.C., Chie W.C., Chang S.C. Prognosis of adult patients with bloodstream infection caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2007, 59:181-190.
29. Kim S.H., Park W.B., Lee K.D., Kang C.I., Bang J.W., Kim H.B., et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bloodstream infection. J Antimicrob Chemother 2004, 54:489-497.
30. The Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2006, The Clinical and Laboratory Standards Institute, Wayne, PA, M7-A4. 7th ed.
31. The Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement M100-S18 2008, The Clinical and Laboratory Standards Institute, Wayne, PA.
32. Hiramatsu K., Kihara H., Yokota T. Analysis of borderline-resistant strains of methicillin-resistant Staphylococcus aureus using polymerase chain reaction. Microbiol Immunol 1992, 36:445-453.
33. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015.
34. Blot S.I., Vandewoune K.H., Hoste E.A., Colardyn F.A. Outcome and attributable mortality in critically ill patients with bloodstream infection involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002, 162:2229-2235.
35. Harbarth S., Rutschmann O., Sudre P., Pittet D. Impact of methicillin resistance on the outcome of patients with bloodstream infection caused by Staphylococcus aureus. Arch Intern Med 1998, 158:182-189.
36. Romero-Vivas J., Rubio M., Fernandez C., Picazo J.J. Mortality associated with nosocomial bloodstream infection due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995, 21:1417-1423.
37. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
38. Rybak M., Lomaestro B., Rotschafer J.C., Moellering R., Craig W., Billeter M., et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Disease Pharmacists. Am J Health Syst Pharm 2009, 66:82-98.
39. Roghmann M.C. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bloodstream infection. Arch Intern Med 2000, 160:1001-1004.